Author Details

Ядгаров, М. Я.

Issue Section Title File
Vol 19, No 1 (2020) ORIGINAL ARTICLES Non-invasive prediction of an unfavorable histological variant in patients with neuroblastic tumors using the quantitative and semiquantitative assessment of ¹²³I-MIBG uptake PDF
(Rus)
Vol 20, No 4 (2021) ORIGINAL ARTICLES The value of single-photon emission computed tomography combined with computed tomography imaging in ¹²³I-Metaiodobenzylguanidine scintigraphy in children with neuroblastoma PDF
(Rus)
Vol 19, No 4 (2020) ПЕРЕДОВАЯ СТАТЬЯ Pharmacokinetics of 13-cis-Retinoic acid in high-risk neuroblastoma patients PDF
(Rus)
Vol 19, No 4 (2020) ORIGINAL ARTICLES Bilateral adrenal neuroblastoma: clinical presentation, diagnostic and therapeutic approaches, treatment results PDF
(Rus)
Vol 21, No 1 (2022) LITERATURE REVIEW Predictive value of metabolic parameters of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography for survival rates of children with lymphoma (a metaanalysis and literature review) PDF
(Rus)
Vol 21, No 2 (2022) LITERATURE REVIEW The impact of response to induction chemotherapy on the event-free and overall survival in patients with high-risk neuroblastoma: a systematic review and meta-analysis PDF
(Rus)
Vol 22, No 2 (2023) ORIGINAL ARTICLES The results of therapy in patients with high-risk neuroblastoma: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology PDF
(Rus)
Vol 22, No 4 (2023) LITERATURE REVIEW The diagnostic roles of fused 18F-fluorodeoxyglucose positron emission tomography/computed tomography and bone scintigraphy in children and young adults with bone sarcomas: a systematic review and meta-analysis PDF
(Rus)
Vol 23, No 1 (2024) ORIGINAL ARTICLES Visual and quantitative assessment of interim 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in children with Hodgkin lymphoma PDF
(Rus)
Vol 23, No 1 (2024) ORIGINAL ARTICLES Tolerability and toxicity of induction chemoimmunotherapy with dinutuximab beta in newly diagnosed patients with high-risk neuroblastoma PDF
(Rus)
Vol 23, No 3 (2024) ORIGINAL ARTICLES Second malignant neoplasms after neuroblastoma treatment: a single center experience PDF
(Rus)